Federal health agencies on Tuesday recommended pausing the use of the Johnson & Johnson vaccine after a small number of people experienced “a rare and severe type of blood clot” after receiving the shot.

The Food and Drug Administration and the Centers for Disease Control and Prevention issued a statement saying they were “recommending a pause in the use of this vaccine out of an abundance of caution.”

Some 6.8 million people have received the single-shot vaccine in the United States. Of these, six have experienced the clot, the agencies said, adding: “Right now, these adverse events appear to be extremely rare.”

The news was first reported by The New York Times.

This is a breaking news story. Please check back for updates.

Source: | This article originally belongs to Nbcnews.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Fed’s Neel Kashkari Now Sees Two 2022 Rate Rises Amid Inflation Surge

Federal Reserve Bank of Minneapolis President Neel Kashkari, who has been one…

FDA appears skeptical about over-the-counter birth control pill

Food and Drug Administration scientists on Friday expressed skepticism about whether the…

Black widow in Texas? After 5-time bride is charged in husband’s murder, other deaths get a fresh look

For David George and Sarah Hartsfield, the first eight months of 2018…

Harley-Davidson Posts Higher Revenue on More Shipments

Business North American retail sales slip 5%, dragged down by lower dealer…